EGS Healthcare Capital Partners is a healthcare private equity firm that invests in late stage private and emerging public healthcare
EGS Healthcare Capital Partners is a healthcare private equity firm that invests in late stage private and emerging public healthcare companies with promising commercial products that are either on the market or in late stages of development. The Principals of the firm presently manage two funds with combined committed capital of more than $135 million.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 21, 2006
EKOS Corporation
|
Series C | $26M | Health Care | — |
Oct 10, 2005
OptiScan Biomedical
|
Series Unknown | $36M | Biotechnology | — |
Aug 23, 2005
Cerexa Inc.
|
Series A | $50M | Biotechnology | — |
May 23, 2005
Endius
|
Series Unknown | $15M | Health Care | — |
Feb 18, 2005
EKOS Corporation
|
Series B | $18M | Health Care | — |
EGS Healthcare Capital Partners has had 7 exits. EGS Healthcare Capital Partners most notable exits include EKOS Corporation , Alveolus
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
May 23, 2013 | EKOS Corporation | M&A | Health Care | Detail |
Feb 19, 2009 | Alveolus | M&A | Medical | Detail |
May 31, 2007 | Jazz Pharmaceuticals | IPO | Biotechnology | Detail |
Feb 9, 2007 | Endius | M&A | Health Care | Detail |
Dec 14, 2006 | Cerexa Inc. | M&A | Biotechnology | Detail |